Sarepta Therapeutics Inc (NASDAQ:SRPT)

Delayed Data
As of May 18
 -2.83 / -3.97%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 19 analysts offering 12-month price forecasts for Sarepta Therapeutics Inc have a median target of 114.00, with a high estimate of 181.00 and a low estimate of 74.00. The median estimate represents a +66.52% increase from the last price of 68.46.

Analyst Recommendations

The current consensus among 21 polled investment analysts is to Buy stock in Sarepta Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 11.13%
Growthannually 9.25%


Growthquarterly 4.73%
Growthannually 27.75%
Key to the earnings and sales forecast charts.